Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade with Rituximab in Relapsed or Refractory Follicular Lymphoma
NCT00312845Phase 3Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Mar 2006
- Primary completion
- Jun 2010
- Countries
- 32
01
Overview
A Phase 3 trial of bortezomib in follicular lymphoma (FL), sponsored by Millennium Pharmaceuticals. Started Mar 2006; status: completed.
02
Drugs
bortezomib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00312845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312845.